AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
MNSO
MINISO Group Holding Limited
There isn't enough reported data to score MNSO yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MNSO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
MNSO's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MNSO in the historical PE scenario, which offers more potential upside but is not a forecast.
MNSO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $9.54 | -13% |
| Current | 18x | $10.94 | — |
| Fair | 20x | $12.49 | +14% |
| Expensive | 49x | $29.81 | +173% |
Historical ranges are pointers, not guarantees.
MNSO's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MNSO Forward outlook
There aren't enough analyst estimates for MNSO to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MNSO on earnings, with more consistent year-over-year improvement.
MNSO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.61 | -46% |
| Q1 2026 | $0.99 | -16% |
| Q4 2025 | $0.58 | -54% |
| Q3 2025 | $1.04 | -12% |
| Q2 2025 | $1.13 | -2.6% |
| Q1 2025 | $1.18 | +3.5% |
| Q4 2024 | $1.26 | +19% |
| Q3 2024 | $1.18 | +40% |
MNSO's earnings per share have fallen from their peak: $0.61 over the past year, against $1.26 in late 2024.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MNSO on profitability, with a higher operating margin.
MNSO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $869.5M | +17% |
| Q1 2026 | $848.5M | +28% |
| Q4 2025 | $925.6M | +31% |
| Q3 2025 | $869.9M | +28% |
| Q2 2025 | $745.3M | +23% |
| Q1 2025 | $664.4M | +19% |
| Q4 2024 | $707.2M | +23% |
| Q3 2024 | $678.7M | +19% |
MNSO has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | -2.8 points |
| Q1 2026 | 12% | -3.4 points |
| Q4 2025 | 14% | -6.6 points |
| Q3 2025 | 14% | -4 points |
| Q2 2025 | 16% | -2.9 points |
| Q1 2025 | 16% | -4.4 points |
| Q4 2024 | 20% | +0.4 points |
| Q3 2024 | 18% | -2.8 points |
MNSO's operating margin was 13% last quarter, down 2.8 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
MNSO has the stronger cash trend. Its trailing FCF is down 100% versus its history, compared with AMZN at down 619%.
MNSO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
| Q2 2024 | $0 | $0 |
MNSO's free cash flow was $0 over the past year, against $0 the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MNSO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +3.1M shares |
| 1 year | +0.1% | +218K shares |
| 3 years | -1.2% | -3.9M shares |
| 5 years | +6.6% | +19.3M shares |
| Available history | -1.3% | -4.2M shares |
MNSO has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MNSO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | -0.9x | Net Cash |
| Q3 2024 | 0.1x | Very low |
MNSO has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MNSO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.6 | Neutral |
| Stochastic | 50.4 | Neutral |
MNSO's weekly RSI is 45 (neutral) and its Stochastic is 50 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MNSO PE vs Consumer Cyclical Sector
| Metric | MNSO | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.1% above |
| PE % | 34 | 48 | 14 pts below |
MNSO has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MNSO on trend strength, trading above more of its moving averages.
MNSO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.96 | 9.8% above |
| 20 week MA | $10.7 | 2.2% above |
| 50 week MA | $14.3 | 23% below |
| 100 week MA | $17.5 | 37% below |
| 200 week MA | $18.6 | 41% below |
MNSO has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 41% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over MNSO on returns for 2026, with the stronger performance.
MNSO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.2 | $31.0 | +34% |
| 2021 | $31.0 | $10.1 | -68% |
| 2022 | $10.1 | $11.3 | +12% |
| 2023 | $11.3 | $20.4 | +81% |
| 2024 | $20.4 | $24.1 | +18% |
| 2025 | $24.1 | $19.6 | -18% |
| 2026 YTD | $19.6 | $10.9 | -44% |
MNSO is down 44% so far in 2026, after finishing higher in four of the previous six years.